Bacteriophages and their implications on future biotechnology: A review

Virology Journal

Volumn 9, Issue , 2012, Pages

  Ul Haq, Irshad ^a   Chaudhry, Waqas Nasir ^a   Akhtar, Maha Nadeem ^a   Andleeb, Saadia ^a   Qadri, Ishtiaq ^a  

^a NATIONAL UNIVERSITY OF SCIENCES AND TECHNOLOGY   (Pakistan)

Author keywords

Antibiotics; Bacteriophage; Biocontrol; Phage therapy; Vaccine

Indexed keywords

VACCINE; ANTIINFECTIVE AGENT;

AGRICULTURE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIOPHAGE; BIOLOGICAL CONTROL AGENT; BIOLOGY; BIOPROCESS; BIOTECHNOLOGY; DRUG DELIVERY SYSTEM; GENE TARGETING; HUMAN; NONHUMAN; PETROCHEMICAL INDUSTRY; PHAGE DISPLAY; REVIEW; ANIMAL; BACTERIUM; GENETICS; METHODOLOGY; PHYSIOLOGY; VIROLOGY;

BACTERIA (MICROORGANISMS);

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIOPHAGES; BIOLOGICAL CONTROL AGENTS; BIOTECHNOLOGY; HUMANS; VACCINES;

EID: 84857657370     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-9     Document Type: Review

References (64)

1. Bacteriophages and biotechnology: vaccines, gene therapy and antibacterials. Clark JR, March JB, Trends Biotechnol 2006 24 5 212 218 10.1016/j.tibtech.2006.03.003 16567009
2. Tailed bacteriophages: the Caudovirales. Ackerman HW, Adv Virus Res 1998 51 135 201 9891587
3. Phage therapy: a reappraisal of bacteriophages as antibiotics. Inal JM, Arch Immunol Ther Exp 2003 51 4 237 244 (Pubitemid 37040064)
4. Bacteriophage discovered. Summers WC, Felix d'Herelle and the Origins of Molecular Biology Yale University Press 1999 47 59 21787081
5. Taking aim on bacterial pathogens: from phage therapy to enzybiotics. Hermoso JA, Garcia JL, Garcia P, Curr Opin Microbiol 2007 10 5 461 472 10.1016/j.mib.2007.08.002 17904412 (Pubitemid 350064581)
6. Studies on Asiatic cholera. D'Herelle F, Malone RH, Lahiri MN, Indian Med Res Mem 1927 14 1
7. Bacteriophage therapy in humans. Sulakvelidze A, Kutter E, Bacteriophages: Biology and Applications CRC Press, Kutter E, Sulakvelidze A, 2005 381 436
8. Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics. Smith HW, Huggins MB, J Gen Microbiol 1982 128 2 307 318 7042903 (Pubitemid 12159900)
9. Bacteriophage therapy. Summers WC, Annu Rev Microbiol 2001 55 437 451 10.1146/annurev.micro.55.1.437 11544363 (Pubitemid 32978113)
10. Hausler T, Viruses vs. Superbugs: A Solution to the Antibiotics Crisis? London: Macmillan 2007
11. Bacteriophage therapy. Sulakvelidze A, Alavidze Z, Morris JG Jr, Antimicrob Agents Chemother 2001 45 3 649 659 10.1128/AAC.45.3.649-659.2001 11181338 (Pubitemid 32182003)
12. Bacteriophage penetration in vertebrates. Dabrowska K, Switaa-Jelen K, Opolski A, Weber-Dabrowska B, Gorski A, J Appl Microbiol 2005 98 1 7 13 10.1111/j.1365-2672.2004.02422.x 15610412 (Pubitemid 40139261)
13. Bacterial viruses as human vaccines? Clark JR, March JB, Expert Rev Vaccines 2004 3 4 463 476 10.1586/14760584.3.4.463 15270651 (Pubitemid 39061711)
14. Enzymes for anti-infective therapy: phage lysins. Lo' pez R, Garc'a E, Garc'a P, Drug Discov Today Ther Strateg 2004 1 469 474 10.1016/j.ddstr.2004.09. 002 (Pubitemid 40197593)
15. Bacteriophage lytic enzymes: novel anti infectives. Fischetti VA, Trends Microbiol 2005 13 10 491 496 10.1016/j.tim.2005.08.007 16125935 (Pubitemid 41317527)
16. Bacteriophage endolysins as a novel class of antibacterial agents. Borysowski J, Weber-Dabrowska B, Gorski A, Exp Biol Med 2006 231 4 366 377
17. Use of genetically engineered phage to deliver antimicrobial agents to bacteria: an alternative therapy for treatment of bacterial infections. Westwater C, Kasman LM, Schofield DA, Werner PA, Dolan JW, Schmidt MG, et al. Antimicrob Agents Chemother 2003 47 4 1301 1307 10.1128/AAC.47.4.1301-1307.2003 12654662 (Pubitemid 36368589)
18. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Smith GP, Science 1985 228 4705 1315 1317 10.1126/science.4001944 4001944 (Pubitemid 15000355)
19. Phage display in pharmaceutical biotechnology. Sidhu SS, Curr Opin Biotechnol 2000 11 6 610 616 10.1016/S0958-1669(00)00152-X 11102798
20. Biotechnological applications of phage and cell display. Benhar I, Biotechnol Adv 2001 19 1 1 33 10.1016/S0734-9750(00)00054-9 14538090 (Pubitemid 32232516)
21. Phage display: practicalities and prospects. Willats WG, Plant Mol Biol 2002 50 6 837 854 10.1023/A:1021215516430 12516857 (Pubitemid 36034980)
22. Phage display for detection of biological threat agents. Petrenko VA, Vodyanoy VJ, J Microbiol Methods 2003 53 2 253 262 10.1016/S0167-7012(03)00029-0 12654496 (Pubitemid 36332359)
23. Phage display as a tool for the directed evolution of enzymes. Fernandez-Gacio A, Uguen M, Fastrez J, Trends Biotechnol 2003 21 9 408 414 10.1016/S0167-7799(03)00194-X 12948674 (Pubitemid 37025778)
24. Making antibodies by phage display technology. Winter G, Griffiths AD, Hawkins RE, Hoogenboom HR, Annu Rev Immunol 1994 12 433 455 10.1146/annurev.iy. 12.040194.002245 8011287
25. Bacteriophage-mediated protein delivery into the central nervous system and its application in immunopharmacotherapy. Dickerson TJ, Kaufmann GF, Janda KD, Expert Opin Biol Ther 2005 5 6 773 781 10.1517/14712598.5.6.773 15952908 (Pubitemid 40873886)
26. The application of the phage fluorescent antiphage staining system in the specific identification of Listeria monocytogenes. I. Species specificity and immunofluorescent sensitivity of Listeria monocytogenes phage observed in smear preparations. Watson BB, Eveland WC, J Infect Dis 1965 115 4 363 369 10.1093/infdis/115.4.363 4953784
27. Near on-line detection of enteric bacteria using lux recombinant bacteriophage. Kodikara CP, Crew HH, Stewart GS, FEMS Microbiol Lett 1991 67 3 261 265 1769532
28. Rapid and sensitive detection method of a bacterium by using a GFP reporter phage. Funatsu T, Taniyama T, Tajima T, Tadakuma H, Namiki H, Microbiol Immunol 2002 46 6 365 369 12153113 (Pubitemid 34712854)
29. Fluorescently labeled virus probes show that natural virus populations can control the structure of marine microbial communities. Hennes KP, Suttle CA, Chan AM, Appl Environ Microbiol 1995 61 10 3623 3627 16535146 (Pubitemid 26452036)
30. Development and characterization of a fluorescent-bacteriophage assay for detection of Escherichia coli O157:H7. Goodridge L, Chen J, Griffiths M, Appl Environ Microbiol 1999 65 1397 1404 10103228 (Pubitemid 29173662)
31. Adenylate kinase amplification of ATP bioluminescence for hygiene monitoring in the food and beverage industry. Corbitt AJ, Bennion N, Forsythe SJ, Lett Appl Microbiol 2000 30 6 443 447 10.1046/j.1472-765x.2000.00744.x 10849273 (Pubitemid 30386794)
32. Genetic engineering for bioluminescent bacteria. Stewart GSAB, Smith T, Denyer S, Food Sci Technol Today 1989 3 19 22
33. Toward cell-targeting gene therapy vectors: selection of cell-binding peptides from random peptide-presenting phage libraries. Barry MA, Dower WJ, Johnston SA, Nat Med 1996 2 3 299 305 10.1038/nm0396-299 8612228 (Pubitemid 26080650)
34. Mammalian cell binding and transfection mediated by surface-modified bacteriophage lambda. Dunn IS, Biochimie 1996 78 10 856 861 10.1016/S0300- 9084(97)84338-6 9116055 (Pubitemid 27060984)
35. Targeting bacteriophage to mammalian cell surface receptors for gene delivery. Larocca D, Witte A, Johnson W, Pierce GF, Baird A, Hum Gene Ther 1998 9 16 2393 2399 10.1089/hum.1998.9.16-2393 9829538 (Pubitemid 28523988)
36. Gene transfer to mammalian cells using genetically targeted filamentous bacteriophage. Larocca D, Kassner PD, Witte A, Ladner RC, Pierce GF, Baird A, FASEB J 1999 13 6 727 734 10094933 (Pubitemid 29156404)
37. Cell binding and internalization by filamentous phage; displaying a cyclic Arg-Gly-Asp-containing peptide. Hart SL, Knight AM, Harbottle RP, Mistry A, Hunger HD, Cutler DF, et al. J Biol Chem 1994 269 17 12468 12474 8175653 (Pubitemid 24202027)
38. Phage display selection of a peptide DNaseII inhibitor that enhances gene delivery. Sperinde JJ, Choi SJ, Szoka FC Jr, J Gene Med 2001 3 2 101 108 10.1002/jgm.165 11318108 (Pubitemid 33685436)
39. Mammalian cell transduction and internalization properties of lambda phages displaying the full-length adenoviral penton base or its central domain. Piersanti S, Cherubini G, Martina Y, Salone B, Avitabile D, Grosso F, et al. J Mol Med 2004 82 7 467 476 15150649 (Pubitemid 39044286)
40. Basic peptides as functional components of non-viral gene transfer vehicles. Nakanishi M, Eguchi A, Akuta T, Nagoshi E, Fujita S, Okabe J, et al. Curr Protein Pept Sci 2003 4 2 141 150 10.2174/1389203033487234 12678853 (Pubitemid 36834013)
41. Molecular heterogeneity of the vascular endothelium; revealed by in vivo phage display. Rajotte D, Arap W, Hagedorn M, Koivunen E, Pasqualini R, Ruoslahti E, J Clin Invest 1998 102 7 430 437 9664085 (Pubitemid 28335203)
42. Peptide-mediated transcytosis of phage display vectors in MDCK cells. Ivanenkov VV, Menon AG, Biochem Biophys Res Commun 2000 276 1 251 257 10.1006/bbrc.2000.3358 11006114
43. A general strategy to identify mimotopes of pathological antigens using only random peptide libraries and human sera. Folgori A, Tafi R, Meola A, Felici F, Galfre G, Cortese R, et al. EMBO J 1994 13 9 2236 2243 7514533 (Pubitemid 24139738)
44. Induction of anti-carbohydrate antibodies by phage library-selected peptide mimics. Phalipon A, Folgori A, Arondel J, Sgaramella G, Fortugno P, Cortese R, Sansonetti PJ, Felici F, Eur J Immunol 1997 27 10 2620 2625 10.1002/eji.1830271022 9368618 (Pubitemid 27453852)
45. Derivation of vaccines from mimotopes. Immunologic properties of human hepatitis B virus surface antigen mimotopes displayed on filamentous phage. Meola A, Delmastro P, Monaci P, Luzzago A, Nicosia A, Felici F, Cortese R, Galfrè G, J Immunol 1995 154 7 3162 3172 7534789
46. Random-peptide libraries and antigen fragment libraries for epitope mapping and the development of vaccines and diagnostics. Irving MB, Pan O, Scott JK, Curr Opin Chem Biol 2001 5 3 314 324 10.1016/S1367-5931(00)00208-8 11479124 (Pubitemid 32718529)
47. Epitope identification and discovery using phage display libraries: applications in vaccine development and diagnostics. Wang LF, Yu M, Curr Drug Targets 2004 5 1 1 15 14738215 (Pubitemid 38081739)
48. Uptake and processing of modified bacteriophage M13 in mice: implications for phage display. Molenaar TJ, Michon I, de Haas SA, Van Berkel TJ, Kuiper J, Biessen EA, Virology 2002 293 1 182 191 10.1006/viro.2001.1254 11853411
49. Interferon production by T4 coliphage. Kleinschmidt WJ, Douthart RJ, Murphy EB, Nature 1970 228 5266 27 30 10.1038/228027a0 4318493
50. Genetic immunization against hepatitis B using whole bacteriophage lambda particles. March JB, Clark JR, Jepson CD, Vaccine 2004 22 13-14 1666 1671 10.1016/j.vaccine.2003.10.047 15068849 (Pubitemid 38447214)
51. Bacteriophage lambda is a highly stable DNA vaccine delivery vehicle. Jepson CD, March JB, Vaccine 2004 22 19 2413 2419 10.1016/j.vaccine.2003.11.065 15193403 (Pubitemid 38757338)
52. Bacteriophage-mediated nucleic acid immunization. Clark JR, March JB, FEMS Immunol Med Microbiol 2004 40 1 21 26 10.1016/S0928-8244(03)00344-4 14734182 (Pubitemid 38083354)
53. Peptides identified through phage display direct immunogenic antigen to dendritic cells. Curiel TJ, Morris C, Brumlik M, Landry SJ, Finstad K, Nelson A, et al. J Immunol 2004 172 12 7425 7431 15187120 (Pubitemid 38747604)
54. A library-selected, Langerhans cell targeting peptide enhances an immune response. McGuire MJ, et al. DNA Cell Biol 2004 23 11 742 752 10.1089/dna.2004.23.742 15585132 (Pubitemid 39577749)
55. H-mutant bacteriophages as a potential biocontrol of bacterial blight of geranium. Flaherty JE, Harbaugh BK, Jones JB, Somodi GC, Jackson LE, HortSci 2001 36 98 100 (Pubitemid 32200692)
56. Biocontrol of bacterial blotch of the cultivated mushroom with lytic phages: some practical considerations. Science and cultivation of edible fungi, 2. Munsch P, Olivier JM, Proceedings of the 14th International Congress 1995 595 602
57. Bacteriophage ecology and plants. APSnet Feature. Gill J, Abedon ST, http://www.apsnet.org/publications/apsnetfeatures/Pages/BacteriophageEcology. aspx
58. Control of microbiofouling using bacteriophage 2. Detection of phages and fundamental study of their lytic effect on fouling bacteria. Sakaguchi I, Shinshima K, Kawaratani K, Sugai O, Denryoku Chuo Kenkyusho Hokoku 1989 1 32
59. Food biopreservation: promising strategies using bacteriocins, bacteriophages and endolysins. García P, Rodríguez L, Rodríguez A, Martínez B, Trends Food Sci Technol 2010 21 373 382 10.1016/j.tifs.2010.04.010
60. Reduction of experimental Salmonella and Campylobacter contamination of chicken skin by application of lytic bacteriophages. Goode D, Allen VM, Barrow PA, Appl Environ Microbiol 2003 69 8 5032 5036 10.1128/AEM.69.8.5032-5036.2003 12902308 (Pubitemid 36992978)
61. Effect of phage on survival of Salmonella enteritidis during manufacture and storage of cheddar cheese made from raw and pasteurized milk. Modi R, Hirvi Y, Hill A, Griffiths MW, J Food Prot 2001 64 7 927 933 11456198 (Pubitemid 32643925)
62. Combined antimicrobial effect of nisin and a listeriophage against Listeria monocytogenes in broth but not in buffer or on raw beef. Dykes GA, Moorhead SM, Int J Food Microbiol 2002 73 1 71 81 10.1016/S0168-1605(01)00710-3 11883676 (Pubitemid 34143087)
63. Biocontrol of Listeria monocytogenes on fresh-cut produce by treatment with lytic bacteriophages and a bacteriocin. Leverentz B, Conway WS, Camp MJ, Janisiewicz WJ, Abuladze T, Yang M, Saftner R, Sulakvelidze A, Appl Environ Microbiol 2003 69 8 4519 4526 10.1128/AEM.69.8.4519-4526.2003 12902237 (Pubitemid 36992907)
64. Control of Brochothrix thermosphacta spoilage of pork adipose tissue using bacteriophages. Greer GG, Dilts BD, J Food Prot 2002 65 5 861 863 12030302 (Pubitemid 34494841)